ORCHARD PARK, NY – October 8, 2012 ValueCentric, the leader in Connected Healthcare Intelligence, and the American Pharmacy Alliance (APA), the most influential technology partnership collective for independent and small chain pharmacies in the United States, today announced that they have entered into a strategic agreement to jointly deliver data solutions that connect pharmaceutical manufacturers with store-level data for independent pharmacies.
Through this relationship, ValueCentric and the APA will offer on-demand data, reporting and analytics through ValueCentric’s award-winning healthcare intelligence platform, ValueTrak. This comprehensive supply channel program will deliver data and analytics associated with independent store-level prescription data from participating stores among APA’s 12,000 affiliated pharmacies. The program will deliver insights that pharmaceutical manufacturers can use to better focus supply chain operations, maximize marketing efforts, develop accurate, predictive financial models and develop a truly pragmatic product lifecycle plan.
“APA and its pharmacy system members have a very real commitment to our goal of expanding and improving patient-level services and adding more efficiency to the healthcare delivery system,” said Karl Steele, President of APA. “ValueCentric is an ideal partner to help us meet that goal. Through programs like this, pharmaceutical manufacturers will be able to more easily connect with independent pharmacies to deliver more effective patient care.”
Established in 1996, The American Pharmacy Alliance has long enjoyed a reputation as a trusted advocate and organization dedicated to the success and advancement of independent pharmacies. The Alliance maintains a uniform channel of 12,000 independent pharmacies within the United States. Through the APA data program, pharmaceutical manufacturers will have access to unique and meaningful prescription data elements, including Location ID, Prescription Details, Payment Methods and Non-Identifiable Patient Profiles. Leveraging this information, manufacturers can build structured and highly-targeted sales and marketing plans, as well as an optimal product lifecycle plan. The program will deliver a daily stream of empirically-supported evidence that will help support or modify plans.
The ValueCentric – APA data program represents another critical element in ValueCentric’s dedication to its role as an industry thought-leader, continuing upon the company’s objective to offer broad, holistic intelligence solutions. Pharmaceutical manufacturers now have the ability to view actual store-level intelligence from across the pharmacy spectrum, from large chain retail through its Walgreens data program, to regionalized mass-market chains through its PDX-Rx.com relationship, and now to a broad spectrum of independent pharmacies with the APA.
“ValueCentric is thrilled to be working with the American Pharmacy Alliance and its members,” said Dave Janca, Founder and CEO of ValueCentric. “This program breaks new ground in the area of near real-time data services, channel transparency and store-level analytics. The views into the independent retail pharmacy environment will provide the manufacturers the granularity of data that’s critically important to their planning and their efforts to be more proactive in support of community pharmacy. In addition, ValueCentric will be establishing a comprehensive data repository for the APA membership to improve their knowledge of the broader marketplace.”
As the leader in connected healthcare intelligence, ValueCentric’s mission is to provide unprecedented market insights and enhanced business relationships through shared actionable information. An early pioneer in cloud-based services, ValueCentric’s innovative technologies allow healthcare companies to leverage critical channel information to drive transformational decision making and business outcomes. ValueCentric has helped to reshape the face of healthcare intelligence by changing the scope, timeliness and accessibility of information resulting in improved business performance. Over 200 marquee customers from throughout the healthcare spectrum, including AstraZeneca, Johnson & Johnson, Merck and Bristol Myers trust ValueCentric.
For more information, please visit www.ValueCentric.com, www.ValueCentricIQ.com, or connect with us on Twitter at @ValueCentricLLC and @ValueCentricIQ.